Delivery Order SPE2DB20D1100-SPE2DB25FE1FB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Meclizine 25 mg, with a ceiling value of $3,507.62 under a firm fixed-price contract type. The award was made on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,019.89 to AmerisourceBergen Drug Corp for Meclizine 25 mg tablets (100-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical supply transaction under the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of 1,000 tablets of Meclizine 25 mg, a medication commonly used to treat nausea and vertigo. This non-set-aside, competitively awarded contract is structured as a firm fixed-price delivery order with a ceiling value of $2,506.47 and an ultimate completion date of July 25, 2025. The place of performance is AmerisourceBergen Drug Corp's corporate office location in Conshohocken,...
- The Defense Logistics Agency Troop Support Medical awarded a $29,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 boxes of 25mg meclizine tablets to be delivered to their Conshohocken, Pennsylvania facility by June 30, 2023. Amerisourcebergen will provide 100 boxes containing 100 tablets each of the motion sickness drug meclizine under the terms of this contract for the Defense Logistics Agency's medical supply needs. No subcontractors or set aside...
- This federal contract award is a delivery order valued at $1,072.32 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the supply of MECLIZINE 25 MG TABLET 100S, a medication, with a performance period ending on July 10, 2025. This order is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $256 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 bottles of 25mg Meclizine tablets. The order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and DoD customers. Performance will take place in Conshohocken, Pennsylvania over a one day period from June 15 to June 16, 2023. No subcontractors or set aside designations were identified. This delivery order...
- The Defense Logistics Agency Troop Support Medical awarded a $38,390 firm fixed price delivery order to Amerisourcebergen Drug Corporation for meclizine hydrochloride. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements. No subcontractors or additional context were provided regarding DLA's use of the medication. The single delivery order was issued on September 7, 2023 and concludes on...
- The Defense Logistics Agency awarded a $25,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 boxes of 25mg meclizine tablets. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility in performance spanning August 17-18, 2023. The DLA utilizes indefinite-delivery/indefinite-quantity contracts to support various medical commodity requirements for the Department of Defense. No set aside designation or...
- The Defense Logistics Agency awarded a $1,073 delivery order contract to Amerisourcebergen Drug Corporation for 1000 boxes of 25mg Meclizine tablets. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning August 16-17, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency is a combat logistics support agency within the Department of Defense responsible for worldwide logistics...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $55,480 to Amerisourcebergen Drug Corporation for the supply of 4561937695 tablets of 25mg meclizine. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by August 25, 2023 under the terms of the contract. The parent company, Amerisourcebergen Corporation, will support performance through its Amerisourcebergen Corporation...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1FBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Meclizine 25 mg tablets (100-count) with a ceiling value of $2,242.00 under a firm fixed-price contract. The award was made on September 25, 2025, with an ultimate completion date of September 26, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a routine pharmaceutical supply transaction for federal medical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor under this comprehensive global contract vehicle, AmerisourceBergen supplies a wide range of medications and medical commodities to support military healthcare programs, the Defense Health Agency, the U.S. Coast Guard, and other federal healthcare systems. The Meclizine order exemplifies the company's role in providing essential pharmaceutical products across multiple therapeutic domains to federal customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/25/25 |